Cangene (FRA:YGE) YoY EBITDA Growth : -110.37% (As of Oct. 2013)

View and export this data going back to . Start your Free Trial

What is Cangene YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Cangene's YoY EBITDA Growth for the quarter that ended in Oct. 2013 was -110.37%.

Cangene's EBITDA per Share for the three months ended in Oct. 2013 was €-0.01.

Cangene YoY EBITDA Growth Historical Data

The historical data trend for Cangene's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene YoY EBITDA Growth Chart

Cangene Annual Data

Trend

Jul04

Jul05

Jul06

Jul07

Jul08

Jul09

Jul10

Jul11

Jul12

Jul13

YoY EBITDA Growth

Get a 7-Day Free Trial

68.35

-58.27

-45.65

-254.70

191.43

Cangene Quarterly Data
	Jan09	Apr09	Jul09	Oct09	Jan10	Apr10	Jul10	Oct10	Jan11	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13
YoY EBITDA Growth	Get a 7-Day Free Trial															400.00	64.71	579.17	127.98	-110.37

Cangene YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Cangene's YoY EBITDA Growth for the fiscal year that ended in Jul. 2013 is calculated as:

	YoY EBITDA Growth (A: Jul. 2013 )
=	(EBITDA per Share (A: Jul. 2013 )	-	EBITDA per Share (A: Jul. 2012 ))	/	\| EBITDA per Share (A: Jul. 2012 ) \|
=	(0.256	-	-0.28)	/	\| -0.28 \|
=	191.43 %

Cangene's YoY EBITDA Growth for the quarter that ended in Oct. 2013 is calculated as:

	YoY EBITDA Growth (Q: Oct. 2013 )
=	(EBITDA per Share (Q: Oct. 2013 )	-	EBITDA per Share (Q: Oct. 2012 ))	/	\| EBITDA per Share (Q: Oct. 2012 )) \|
=	(-0.014	-	0.135)	/	\| 0.135 \|
=	-110.37 %

Cangene YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Cangene's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Cangene (FRA:YGE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.cangene.com

Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines